180 related articles for article (PubMed ID: 9873535)
41. In vitro and in vivo properties of bicyclic lactam inhibitors: a novel class of low molecular weight peptidomimetic thrombin inhibitors.
Leblond L; Grouix B; Boudreau C; Yang Q; Siddiqui MA; Winocour PD
Thromb Res; 2000 Nov; 100(3):195-209. PubMed ID: 11108907
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and structure-activity relationships of a new class of 1-oxacephem-based human chymase inhibitors.
Aoyama Y; Uenaka M; Konoike T; Iso Y; Nishitani Y; Kanda A; Naya N; Nakajima M
Bioorg Med Chem Lett; 2000 Nov; 10(21):2397-401. PubMed ID: 11078187
[TBL] [Abstract][Full Text] [Related]
43. Structure-activity relationships of substituted benzothiophene-anthranilamide factor Xa inhibitors.
Chou YL; Davey DD; Eagen KA; Griedel BD; Karanjawala R; Phillips GB; Sacchi KL; Shaw KJ; Wu SC; Lentz D; Liang AM; Trinh L; Morrissey MM; Kochanny MJ
Bioorg Med Chem Lett; 2003 Feb; 13(3):507-11. PubMed ID: 12565961
[TBL] [Abstract][Full Text] [Related]
44. 1-Oxacephem-based human chymase inhibitors: discovery of stable inhibitors in human plasma.
Aoyama Y; Uenaka M; Konoike T; Iso Y; Nishitani Y; Kanda A; Naya N; Nakajima M
Bioorg Med Chem Lett; 2000 Nov; 10(21):2403-6. PubMed ID: 11078188
[TBL] [Abstract][Full Text] [Related]
45. Synthesis of potent and highly selective nonguanidine azetidinone inhibitors of human tryptase.
Bisacchi GS; Slusarchyk WA; Bolton SA; Hartl KS; Jacobs G; Mathur A; Meng W; Ogletree ML; Pi Z; Sutton JC; Treuner U; Zahler R; Zhao G; Seiler SM
Bioorg Med Chem Lett; 2004 May; 14(9):2227-31. PubMed ID: 15081014
[TBL] [Abstract][Full Text] [Related]
46. Structure and property based design of factor Xa inhibitors: biaryl pyrrolidin-2-ones incorporating basic heterocyclic motifs.
Young RJ; Borthwick AD; Brown D; Burns-Kurtis CL; Campbell M; Chan C; Charbaut M; Convery MA; Diallo H; Hortense E; Irving WR; Kelly HA; King NP; Kleanthous S; Mason AM; Pateman AJ; Patikis AN; Pinto IL; Pollard DR; Senger S; Shah GP; Toomey JR; Watson NS; Weston HE; Zhou P
Bioorg Med Chem Lett; 2008 Jan; 18(1):28-33. PubMed ID: 18053714
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of bisbenzamidines as inhibitors for matriptase-2.
Beckmann AM; Gilberg E; Gattner S; Huang TL; Vanden Eynde JJ; Mayence A; Bajorath J; Stirnberg M; Gütschow M
Bioorg Med Chem Lett; 2016 Aug; 26(15):3741-5. PubMed ID: 27287367
[TBL] [Abstract][Full Text] [Related]
48. Nonbenzamidine tetrazole derivatives as factor Xa inhibitors.
Quan ML; Ellis CD; He MY; Liauw AY; Woerner FJ; Alexander RS; Knabb RM; Lam PY; Luettgen JM; Wong PC; Wright MR; Wexler RR
Bioorg Med Chem Lett; 2003 Feb; 13(3):369-73. PubMed ID: 12565931
[TBL] [Abstract][Full Text] [Related]
49. [Synthetic inhibitors targeting serine and aspartic acid proteases].
Reboud-Ravaux MC; Boggetto ND; Doucet CE; de Rosny EH; Vergely IB; Thierry NM; Amour AJ
J Pharm Belg; 1996; 51(3):161-4. PubMed ID: 8778349
[TBL] [Abstract][Full Text] [Related]
50. Dibasic inhibitors of human mast cell tryptase. Part 1: synthesis and optimization of a novel class of inhibitors.
Rice KD; Gangloff AR; Kuo EY; Dener JM; Wang VR; Lum R; Newcomb WS; Havel C; Putnam D; Cregar L; Wong M; Warne RL
Bioorg Med Chem Lett; 2000 Oct; 10(20):2357-60. PubMed ID: 11055355
[TBL] [Abstract][Full Text] [Related]
51. 1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase.
Wong T; Groutas CS; Mohan S; Lai Z; Alliston KR; Vu N; Schechter NM; Groutas WC
Arch Biochem Biophys; 2005 Apr; 436(1):1-7. PubMed ID: 15752703
[TBL] [Abstract][Full Text] [Related]
52. The design and synthesis of thrombin inhibitors: analogues of MD805 containing non-polar surrogates for arginine at the P1 position.
Baettig U; Brown L; Brundish D; Dell C; Furzer A; Garman S; Janus D; Kane PD; Smith G; Walker CV; Cockcroft X; Ambler J; Mitchelson A; Talbot MD; Tweed M; Wills N
Bioorg Med Chem Lett; 2000 Jul; 10(14):1563-6. PubMed ID: 10915051
[TBL] [Abstract][Full Text] [Related]
53. Inhibition of bovine beta-trypsin, human alpha-thrombin and porcine pancreatic beta-kallikrein-B by benzamidine and its bis-, tris- and tetra-derivatives: thermodynamic and molecular modeling study.
Menegatti E; Ferroni R; Nastruzzi C; Bortolotti F; Scalia S; Amiconi G; Bolognesi M; Coletta M; Onesti S; Fruttero R
Farmaco; 1991 Nov; 46(11):1297-310. PubMed ID: 1811616
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of human chymase by 2-amino-3,1-benzoxazin-4-ones.
Neumann U; Schechter NM; Gütschow M
Bioorg Med Chem; 2001 Apr; 9(4):947-54. PubMed ID: 11354678
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and analysis of novel bicyclic and bifunctional protease inhibitors.
Jaulent AM; Leatherbarrow RJ
Protein Eng Des Sel; 2004 Sep; 17(9):681-7. PubMed ID: 15486024
[TBL] [Abstract][Full Text] [Related]
56. Pseudo-peptides derived from isomannide as potential inhibitors of serine proteases.
Muri EM; Gomes M; Albuquerque MG; da Cunha EF; de Alencastro RB; Williamson JS; Antunes OA
Amino Acids; 2005 Jun; 28(4):413-9. PubMed ID: 15662562
[TBL] [Abstract][Full Text] [Related]
57. Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity.
Rice KD; Wang VR; Gangloff AR; Kuo EY; Dener JM; Newcomb WS; Young WB; Putnam D; Cregar L; Wong M; Simpson PJ
Bioorg Med Chem Lett; 2000 Oct; 10(20):2361-6. PubMed ID: 11055356
[TBL] [Abstract][Full Text] [Related]
58. Irreversible inhibitors of serine, cysteine, and threonine proteases.
Powers JC; Asgian JL; Ekici OD; James KE
Chem Rev; 2002 Dec; 102(12):4639-750. PubMed ID: 12475205
[No Abstract] [Full Text] [Related]
59. Symmetrical anhydride-type serine protease inhibitors: structure-activity relationship studies of human chymase inhibitors.
Iijima K; Katada J; Hayashi Y
Bioorg Med Chem Lett; 1999 Feb; 9(3):413-8. PubMed ID: 10091694
[TBL] [Abstract][Full Text] [Related]
60. Practical synthesis of a renin inhibitor via a diastereoselective Dieckmann cyclization.
Gauvreau D; Hughes GJ; Lau SY; McKay DJ; O'Shea PD; Sidler RR; Yu B; Davies IW
Org Lett; 2010 Nov; 12(22):5146-9. PubMed ID: 20945851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
